---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000887"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2023-08-21T23:59:59+00:00"
generated_at: "2026-06-11T06:00:47.041102+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma shareholders pass all five proposals at 2023 annual meeting

## Summary
- Claudia Grimaldi elected Class A director with 14.7M for, 1.4M withheld, 11M broker non-votes.
- Ratified Manohar Chowdhry & Associates as auditor for FY2024: 26.9M for, 163K against.
- Approved grant of 3M common shares to employees, advisors, directors; 14.3M for.
- Say-on-pay approved (15.3M for); frequency set at every three years (13.1M for 3 yrs).
- Board adopts triennial advisory vote on executive compensation going forward.

## SEC filing metadata
- accession: 0001185185-23-000887
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2023-08-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000887/0001185185-23-000887-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000887/igcpharma20230821_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000887
- JSON: https://secwatch.observer/filing/0001185185-23-000887.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000887.txt

## Key facts
- Shareholder Votes
  IGC Pharma, Inc. shareholders approved Approve grant of 3,000,000 shares of common stock to employees, advisors, directors, and consultants at the 2023-08-18 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-08-18
  source text: For Against Abstain Broker Non-votes 14,268,013 1,861,386 39,115 11,035,662
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000887/0001185185-23-000887-index.htm
- Shareholder Votes
  IGC Pharma, Inc. shareholders approved Advisory vote on frequency of say-on-pay votes (every three years) at the 2023-08-18 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-08-18
  source text: 5. Approval to, by a non-binding advisory vote, setting the frequency of say-on-pay votes at future annual meetings of stockholders to every three years; 1 YEAR 2 YEARS 3 YEARS Abstain Broker Non-votes 2,429,382 181,013 13,078,308 479,811 11,035,662
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000887/0001185185-23-000887-index.htm
- Shareholder Votes
  IGC Pharma, Inc. shareholders approved Election of Director Claudia Grimaldi at the 2023-08-18 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-08-18
  source text: 1. Election of Directors. Nominee For Withhold Broker Non-votes Claudia Grimaldi 14,740,248 1,428,266 11,035,662
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000887/0001185185-23-000887-index.htm
- Shareholder Votes
  IGC Pharma, Inc. shareholders approved Advisory approval of compensation of named executive officers at the 2023-08-18 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-08-18
  source text: 4. Approval of a non-binding advisory resolution to approve the compensation of the Company’s named executive officers. For Against Abstain Broker Non-votes 15,339,051 769,054 60,409 11,035,662
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000887/0001185185-23-000887-index.htm
- Shareholder Votes
  IGC Pharma, Inc. shareholders approved Ratify appointment of Manohar Chowdhry & Associates as independent registered public accounting firm for 2024 at the 2023-08-18 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-08-18
  source text: 2. Proposal to ratify the appointment of Manohar Chowdhry & Associates as the Company’s independent registered public accounting firm for the 2024 fiscal year. For Against Abstain 26,949,467 163,043 91,666
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518523000887/0001185185-23-000887-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.